Singapore Healthcare Industry 2H12


January 14, 2013
32 Pages - SKU: ISAL4943558
License type:
Countries covered: Singapore

Singapore: Healthcare covers the Asia-Pacific overview, general overview of Singapore, and Singapore healthcare industry including social development and healthcare services. It also covers the market trends and outlook, financing approach, SingaporeMedicine, medical tourism, customer centric initiative, and national electronic health records, plus the profile, comparative matrix and SWOT of the industry leading players: Parkway Holdings Ltd (Parkway), Thomson Medical Centre (TMC), Health Management International Ltd (HMI), and China Healthcare Ltd (China Healthcare).


Additional Information

SG Healthcare provides an overview of the healthcare industry in Singapore and the Asia Pacific. Singapore’s healthcare system is internationally recognised and was ranked 6th out of 191 countries and 1st in Asia in the World Health Report on health systems, hence allowing the country to be well poised to benefit from global trends. In 2011, Singapore’s healthcare services industry had more than 4,300 establishments with about 69,000 employees working in the industry.

The report includes the market trends and outlook of the healthcare industry in Singapore. We examine the financing approach of Singapore’s healthcare industry, medical tourism as well as other initiatives undertaken by the government to improve its healthcare industry. According to the Singapore Tourism Board, Singapore earned SGD 940 million from medical tourism in 2010, a whopping SGD 200 million increase from a year ago.

Also, the report encompasses the profile of leading players in the healthcare industry as well as their respective financial highlights. Among the leading healthcare players in Singapore are Parkway Pantai Limited, Thomson Medical Centre Limited, Health Management International Limited and China Healthcare Limited. Parkway is the largest healthcare provider in Singapore and one of the largest in Asia.
1 Industry Profile
1.1 Healthcare in Asia Pacific
1.2 General Overview of Singapore
1.3 Singapore Healthcare Industry
1.3.1 Social Development
1.3.2 Healthcare Services
2 Market Trends and Outlook
2.1 Financing Approach
2.2 SingaporeMedicine
2.2.1 Medical Tourism
2.2.2 Economic Development Board (EDB)
2.3 Customer-Centric Initiative (CCI)
2.4 National Electronic Health Records System (NEHR)
3 Leading Players and Comparative Matrix
3.1 Leading Players
3.1.1 Parkway Holdings Ltd (Parkway)
3.1.2 Thomson Medical Centre (TMC)
3.1.3 Health Management International LTD (HMI)
3.1.4 China Healthcare LTD (China Healthcare)
3.2 Comparative Matrix
3.3 SWOT Analysis
4. Tables and Charts
Table 1: Life Expectancy of Selected Asian Countries
Table 2: General Economic Statistics (2001-2011)
Table 3: Key Indicators of Health Services (2009-2011)
Table 4: Hospital and Public Sector Clinics (2006-2011)
Table 5: Hospital Admissions and Public Sector Outpatient Attendances
(2006-2011)
Table 6: Average Hospital Inpatient Bill Size Table, Public Hospitals - Medical Specialties (Jan to June 2011)
Table 7: Average Hospital Inpatient Bill Size Table, Private Hospitals - Medical Specialties (Jan to June 2011)
Table 8: Medical Centres that Obtained the Joint Commission International (JCI) * Accreditation
Table 9: Cost of Medical Treatment in Singapore
Table 10: Healthcare Organisations Participating in CCI
Table 11: Financial Highlights of the Leading Players
Chart 1: Global Pharmaceutical Market by Region in 2011
Chart 2: Global Pharmaceutical Market by Region in 2008
Chart 3: Population and Growth Rate (2006-2010)
Chart 4: Social Development in Healthcare Industry (2006-2011)
Chart 5: Revenue Contribution in FY2010 – Parkway
Chart 6: NPATMI Contribution in FY2010 – Parkway
Chart 7: Revenue by Segment – TMC (2009-2010)
Chart 8: Revenue by Segment – HMI (2011-2012)
Chart 9: Total Revenue – China Healthcare (2002-2010)

More Prescription Drugs reports by Emerging Markets Direct Reports

Singapore Pharmaceutical Industry 1H12 by Emerging Markets Direct Reports
Singapore: Pharmaceutical covers the sector overview, sectror size, competitive landscape, enviromental scanning for Singapore. It also covers the market trends and outlook, production index, manufacturing ...
See all reports like this >>

More Singapore Prescription Drugs reports

Singapore Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: The government’s increased commitment to healthcare provision and an increasingly ageingpopulation that has high per-capita pharmaceutical and healthcare expenditure will continue to attractpharmaceutical ...
Singapore Pharmaceutical Industry 1H12 by Emerging Markets Direct Reports
Singapore: Pharmaceutical covers the sector overview, sectror size, competitive landscape, enviromental scanning for Singapore. It also covers the market trends and outlook, production index, manufacturing ...
Antibiotics Market in Singapore to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market ...
Singapore Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: The reduction in healthcare subsidies for permanent residents (PRs) in Singapore, which is to be implemented in two phases over the coming 12 ...
See all reports like this >>

More Singapore reports

D&B Country RiskLine Report: Singapore by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Singapore: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Singapore, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 Singapore Industry & Market Outlook report by Barnes Reports
The 2007 Singapore Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Singapore and 500+ minor industries ...
Singapore (Full Report) by Intellectual Property Exchange
Technology Competitive Intelligence Report: Singapore, a highly developed and successful free market economy, enjoys a remarkably open and corruption-free environment, stable prices, and one of ...
See all reports like this >>

 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!